GW-1000-02

DRUG7 trials

Sponsors

Jazz Pharmaceuticals

Conditions

Multiple SclerosisPainSpasticity

Phase 3

A Study of the Long-term Safety of Sativex Use

CompletedNCT01606137

Jazz PharmaceuticalsMultiple Sclerosis, Pain, Spasticity

Start: 2002-02-28End: 2004-12-31Updated: 2023-05-06

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

CompletedNCT01606176

Jazz PharmaceuticalsMultiple Sclerosis, Pain

Start: 2002-03-31End: 2002-08-31Updated: 2023-01-10

A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

CompletedNCT01606202

Jazz PharmaceuticalsPain

Start: 2002-07-31End: 2005-01-31Updated: 2023-01-10

A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain

CompletedNCT01606189

Jazz PharmaceuticalsPain

Start: 2001-12-31End: 2002-09-30Updated: 2023-01-10

An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

CompletedNCT01610713

Jazz PharmaceuticalsMultiple Sclerosis

Start: 2001-05-31End: 2002-07-31Updated: 2023-01-10

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

CompletedNCT01610700

Jazz PharmaceuticalsMultiple Sclerosis

Start: 2001-05-31End: 2002-07-31Updated: 2023-01-12

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

CompletedNCT01610687

Jazz PharmaceuticalsMultiple Sclerosis, Spasticity

Start: 2001-07-31End: 2005-02-28Updated: 2023-01-10